The role of executive functioning in CBT: a pilot study with anxious older adults

Mohlman, Jan; Gorman, Jack M.

doi:10.1016/j.brat.2004.03.007

Cited by 198 publications

(150 citation statements)

References 40 publications

Supporting

Mentioning

142

Contrasting

Unclassified

Order By: Relevance

“…[161] Indeed, a pilot study of 32 older adults suggested that older adults with GAD and impairments in executive functioning did not respond as well to CBT for their GAD symptoms as those without executive functioning impairments. [162] More research is needed to address whether unique treatments may be warranted for older adults presented with anxiety disorders and cognitive impairment. Finally, further research is needed on the efficacy of psychosocial interventions for SOP, SP, PD, and PTSD for the elderly population.…”

Section: Treatment Efficacymentioning

confidence: 99%

Anxiety disorders in older adults: a comprehensive review

Wolitzky-Taylor¹,

Castriotta²,

Lenze³

et al. 2010

Depress. Anxiety

601

398

View full text Add to dashboard Cite

This review aims to address issues unique to older adults with anxiety disorders in order to inform potential changes in the DSM-V. Prevalence and symptom expression of anxiety disorders in late life, as well as risk factors, comorbidity, cognitive decline, age of onset, and treatment efficacy for older adults are reviewed. Overall, the current literature suggests: (a) anxiety disorders are common among older age individuals, but less common than in younger adults; (b) overlap exists between anxiety symptoms of younger and older adults, although there are some differences as well as limitations to the assessment of symptoms among older adults; (c) anxiety disorders are highly comorbid with depression in older adults; (d) anxiety disorders are highly comorbid with a number of medical illnesses; (e) associations between cognitive decline and anxiety have been observed; (f) late age of onset is infrequent; and (g) both pharmacotherapy and CBT have demonstrated efficacy for older adults with anxiety. The implications of these findings are discussed and recommendations for the DSM-V are provided, including extending the text section on age-specific features of anxiety disorders in late life and providing information about the complexities of diagnosing anxiety disorders in older adults. Depression and Anxiety 27:190-211, 2010.

show abstract

Section: Treatment Efficacymentioning

confidence: 99%

Anxiety disorders in older adults: a comprehensive review

Wolitzky-Taylor¹,

Castriotta²,

Lenze³

et al. 2010

Depress. Anxiety

601

398

View full text Add to dashboard Cite

show abstract

“…34 Effect sizes were based on completers-only data, as intention-to-treat outcome data was not available for all studies. As a number of trials had small samples, effect sizes were corrected using an adjustment, J , to convert effect sizes to Hedges' g. 35 For studies in which multiple treatment arms received CBT, data was collapsed to form one group where treatment was comparable, 36,37 and if not, data from the most relevant CBT group was extracted. 38 In studies in which multiple comparison groups did not receive CBT, data was extracted from the most active comparison condition.…”

Section: Between-group Effect Sizesmentioning

confidence: 99%

Efficacy of Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults: Systematic Review, Meta-Analysis, and Meta-Regression

Hall

Kellett

Berrios

et al. 2016

The American Journal of Geriatric Psychiatry

122

View full text Add to dashboard Cite

Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/) eprints@whiterose.ac.uk https://eprints.whiterose.ac.uk/ Reuse This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) licence. This licence only allows you to download this work and share it with others as long as you credit the authors, but you can't change the article in any way or use it commercially. More information and the full terms of the licence here: https://creativecommons.org/licenses/ Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. and six-month follow-up, significant treatment effects favoring CBT were found in comparison to a waitlist or treatment-as-usual. When CBT was compared with active controls, a small non-significant treatment advantage was found for CBT at the end of treatment, with equivalence of outcomes at follow-up. Treatment effect size of CBT for GAD was significantly associated with attrition rates and depression outcomes. Conclusions: CBT is more helpful than having no treatment for GAD in later life. However, whether CBT shows long-term durability, or is superior to other commonly available treatments (such as supportive psychotherapy), remains to be tested. The relationship between treatment effects for GAD and depression following CBT warrants further research. Efficacy of CBT for GAD in

show abstract

“…Preliminary functional imaging also suggests that CBT may result in significant metabolic changes in the cortical-limbic pathways that may positively impact several of the aspects of cognitive functioning that are aggravated by depression in PD [67]. Other research groups have also highlighted the importance of considering executive functioning when implementing CBT to treat psychiatric disturbances in PD [68], as well as in the non-PD aged [69].…”

Section: Expert Commentary Unique Features Of Dpdmentioning

confidence: 99%

CBT for the treatment of depression in Parkinson’s disease: a promising nonpharmacological approach

Dobkin¹,

Menza²,

Bienfait³

2008

Expert Review of Neurotherapeutics

View full text Add to dashboard Cite

Depression is very common in PD and linked with a faster progression of physical symptoms, greater cognitive decline, and poorer quality of life. Non-pharmacological approaches, like cognitivebehavioral therapy (CBT), for the treatment of depression in Parkinson's disease (dPD) have received little experimental attention despite strong demonstrated efficacy in other geriatric and medical populations. Depressed PD patients often differ from the depressed non-PD elderly in that they present with increased rates of both executive dysfunction and co-morbid psychiatric diagnoses, may differ in their depressive symptom presentation, and typically have caregivers who are highly involved in their treatment. Therefore, it is not possible to conclude that empirically validated treatments in the depressed aged will generalize to those with Parkinson's disease. In order to be most effective for PD patients, CBT should be tailored to their unique needs. Additional controlled research is needed to further explore the efficacy of CBT for dPD.

show abstract

The role of executive functioning in CBT: a pilot study with anxious older adults

Cited by 198 publications

References 40 publications

Anxiety disorders in older adults: a comprehensive review

Anxiety disorders in older adults: a comprehensive review

Efficacy of Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults: Systematic Review, Meta-Analysis, and Meta-Regression

CBT for the treatment of depression in Parkinson’s disease: a promising nonpharmacological approach

Contact Info

Product

Resources

About